Novartis Investigative Site

Syktyvkar 167981

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early